Subscribe to our YouTube channel: 


Hello, nice to meet you, how are you?

What's your name and where are you from?

I'm Amoding Rebecca from Uganda, THR Scholar, first year.

My name is Idris Walizumba from Tanzania, also the first year Scholar, first stage.

Is this your first time at GFN?

Yeah, it's my first time.

And I say this is my first time.

What are your thoughts?

It's really a good thing because with such, I see that the spread of safe nicotine products

that I know it will go out more, because we get to come in different countries and different

people when we come, learn, get the information and take to different parts of the world.

This is how we get to spread that we use, that's why I put it here.

Yes, even myself, I was very, very, very, very kind on the session which I attended.

So I found the new knowledge.

Actually, I understood what is tobacco harm reduction.

I find a lot of differentiation in different areas, they tend to talk about the different

diversity and the perception.

So from my side, actually, I enjoyed, but the most I enjoyed was the issues with the

tobacco harm reduction and the facilitators and the barriers.

I was talking to some here, you know, the tobacco burden is huge,

almost 80% for the total burden of the tobacco harm reduction.

So actually, it's very nice.

And you have to see how I do, talk about harm reduction.

With GFN, it gives us chance as people of Africa, because most time the tobacco harm

reduction is concentrated on the developed countries and Africa is named out.

So with GFN, it gives a chance to even the non-developed countries to get right information

about the tobacco harm reduction and how to spread it to the lower levels so that we can

At the end of the day, we get what we achieve, saving a life, saving lives, when it comes

now to diseases that come about with smoking and what not.

So that's why it really gives us a chance to spread the information to the lowest person

in Africa.

And also, in addition to that, for instance, in my project as a scholar, we have been conducting

the lesson in Tanzania.

We hear about and appreciate the role and knowledge of healthcare workers for tobacco

harm reduction.

Do you really think healthcare workers know about tobacco harm reduction?

What is that?

I was asked that, at least until patients come to the hospital, and then they say, yes,

they quit smoking.

But we have to know.

Do they know about the safe and equal treatment?

So we want to sell tobacco.

So I was very interested, and actually I have to make sure that this product, I can't

from the information which I have got from this ROP, let's jump on a serious task.

Hello again.

You participated in several sessions so far.

Which topic of the conference seems to be most interesting for you?

OK, thank you very much for the good question.

Actually, the most interesting topic for me, it was on the barriers and the facilitator

on quitting or switching to safer nicotine product.

That was interesting for me.

As we were looking on what are the barriers, and specifically in my group, we are looking

specifically at the barriers and facilitator in the women in the low and middle income

countries like Tanzania, which is among the countries where I'm coming from.

That's why I look for the factors like some of the women actually they are afraid to quit

because they are afraid that they will become fat.

And the others, it was like the cost whereby the women, we found that they are not having

money where they can buy this safer nicotine product.

And also other issues about the affordability and accessibility in our country, in low and

middle income countries is a problem.

That's why I want to go to do research and I have learned a lot from this GFN 2023.

So I'm going to implement in my stats, as I told you, my study is looking on the law

and the knowledge of health care workers toward tobacco harm reduction.

Thank you so much.

Thank you.